Gary K. Lee insider trades
Open-market stock purchases and sales by Gary K. Lee, Chief Scientific Officer at Lyell Immunopharma, Inc, from SEC Form 4 filings since Feb 11, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 21, 2026 | LYEL Lyell Immunopharma, Inc | Sold | $22.6K |
| Aug 10, 2026 | LYEL Lyell Immunopharma, Inc | Sold | $1.9K |
| May 11, 2026 | LYEL Lyell Immunopharma, Inc | Sold | $2.5K |
| Feb 11, 2026 | LYEL Lyell Immunopharma, Inc | Sold | $39.1K |
| Feb 10, 2026 | LYEL Lyell Immunopharma, Inc | Sold | $3.4K |
| Feb 10, 2026 | LYEL Lyell Immunopharma, Inc | Bought (not open market) | — |
| Feb 9, 2026 | LYEL Lyell Immunopharma, Inc | Bought (not open market) | — |
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc | Sold | $2.2K |
| Oct 27, 2025 | LYEL Lyell Immunopharma, Inc | Bought (not open market) | — |
Companies traded
- LYEL Lyell Immunopharma, Inc: 9 sales, last Aug 21, 2026